LifeStance Health Group, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2019 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | $9.7M | $-57.4M | $-186.3M | $-215.6M | $-307.2M | $5.7M |
| Depreciation & Amortization | $41.6M | $40.7M | $37.4M | $28.9M | $15.1M | $3.0M |
| Depreciation | — | — | — | — | — | — |
| Amortization | $13.1M | $30.3M | $43.1M | $40.3M | $39.0M | $3.1M |
| Stock-Based Compensation | $74.7M | $76.2M | $99.4M | $187.4M | $259.4M | $54.0K |
| Net Cash from Operating Activities | $146.2M | $107.3M | $-16.9M | $52.8M | $9.4M | $17.0M |
| Investing Activities | ||||||
| Capital Expenditures | $36.1M | $21.6M | $40.5M | $79.3M | $94.5M | $14.3M |
| Business Acquisitions | $0 | $0 | $19.8M | $60.2M | $99.6M | $59.1M |
| Net Cash from Investing Activities | $-36.1M | $-21.6M | $-60.3M | $-139.5M | $-194.1M | $-73.4M |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-16.0M | $-9.9M | $47.4M | $47.3M | $313.9M | $48.5M |
| Net Change in Cash | $94.1M | $75.7M | $-29.8M | $-39.4M | $129.2M | $-7.9M |
| Free Cash Flow | $110.0M | $85.7M | $-57.4M | $-26.5M | $-85.1M | $2.7M |